BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Goodwill

Latest goodwill for AEZS: $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average

Loading

COSCIENS Biopharma Goodwill History

Loading

COSCIENS Biopharma vs. peers: Goodwill Comparison

Loading

COSCIENS Biopharma Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

COSCIENS Biopharma (AEZS) FAQ

COSCIENS Biopharma (AEZS) currently reports a goodwill of $0 as of June 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore COSCIENS Biopharma's goodwill history and peer comparisons.

COSCIENS Biopharma's goodwill changed from $0 to $0 (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

COSCIENS Biopharma reported $0 in goodwill as of June 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for COSCIENS Biopharma, and consider following AEZS for alerts when major investors trade the stock.

COSCIENS Biopharma is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AEZS with unrelated industries.